| Description | Enzyme immunoassay (ELISA) for the determination of human IGFBP-2 in human serum, EDTA-plasma, cerebrospinal fluid, breast milk, amniotic fluid, saliva, and in cell culture medium. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Infliximab (Remicade®, Remsima®, and Inflectra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Indirect ELISA for the determination of human GPIHBP1 Autoantibody in serum, EDTA-plasma, heparin plasma, and post-heparin EDTA-plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the quantitative determination of Progesterone in serum and plasma. FDA exempt, can be used for in-vitro diagnostics. | Enzyme immunoassay (ELISA) for the direct quantitative determination of Total Estrogens in human serum. 510(k) exempt - for in vitro diagnostic use only. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Assay Time | 1 hr 45 mins (incubation) | 2 hours, 15 min. total incubation time. | 2 hour total incubation time. | 1 hr 20 mins (incubation) | 30 min. incubation (RT) + 2 hours (RT) + 30 minute (RT) = 3 hours total incubation time. |